• Cosentyx Shown to Reduce Fatigue for Up to 3 Years in Active AS Patients
  • Sex Differences Found in nr-axSpA Disease Severity, Treatment Response
  • Rinvoq Recommended for EU Approval to Treat Active AS
  • When ‘Imagined’ Pain Becomes a Real Diagnosis
  • Have a DIY Spa Day for Your Aches and Pains
  • Humira Biosimilar AVT02 Accepted for Regulatory Review in US, Europe
  • What My Nightly Struggle With Invisible Illness Looked Like
  • NORD Push for Rare Disease Advisory Councils Focus of Dec. 16 Public Meeting
  • Survey Finds COVID-19 Disrupted Care, Well-Being of Rare Disease Patients in Europe
  • Just Keep Swimming
  • Latest NORD Webinar Offers Insights on Starting Nonprofit, Patient Registry
  • Clinical Trial Data Show Durable Efficacy of Cimzia, Bimekizumab